Hot Low Price Stocks To Watch Right Now

In the debate between growth and value, some may argue value can prevail.

After all, “value” stocks typically boast low price-earnings ratios and other traditional assessment metrics, often looked upon as undervalued relative to its underlying fundamentals. “Growth” stocks are often considered those whose earnings are expected to increase at an above-average rate but don’t necessarily boast the same strong fundamental backdrop.

Chad Morganlander, portfolio manager with Washington Crossing Advisors, recently went overweight value stocks over growth stocks. Here are his reasons why.

Though earnings are coming in quite nicely for growth stocks this quarter, valuations are stretched.

Outsized gains in technology shares, specifically, reduce the relative attractiveness of growth over value at this juncture.

Hot Low Price Stocks To Watch Right Now: Calumet Specialty Products Partners L.P.(CLMT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Calumet Specialty Products Partners (NASDAQ:CLMT) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Saturday.

  • [By Reuben Gregg Brewer]

    Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) is attempting to shift gears as it refocuses around higher-margin refined chemicals products. The plan sounds good on paper, and the independent refiner appears to be making progress. However, after a doubling of the price over the past year, most investors need to think carefully before jumping on this bandwagon. Here’s why.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Hot Low Price Stocks To Watch Right Now: EnLink Midstream, LLC(ENLC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    However, after announcing the sale of its interest in EnLink Midstream Partners (NYSE: ENLK) and EnLink Midstream (NYSE: ENLC) for $3.125 billion in June, it boosted its buyback authorization up to $4 billion. That represents enough cash to retire roughly 20% of its outstanding shares. Devon expects the sale of EnLink to close this July, which will enable it to accelerate the pace of repurchases through the end of 2019.

  • [By Shane Hupp]

    Headlines about EnLink Midstream (NYSE:ENLC) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. EnLink Midstream earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned news stories about the pipeline company an impact score of 45.7727314287906 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Matthew DiLallo]

    The company took a major step in that direction this week after announcing that it had agreed to sell its stakes in midstream companies EnLink Midstream Partners (NYSE:ENLK) and EnLink Midstream (NYSE:ENLC) for $3.125 billion in cash. The shale driller plans to use that cash to repurchase up to $4 billion of its shares through the end of next year, assuming this transaction closes. These moves could unlock significant shareholder value in the coming year.

  • [By Stephan Byrd]

    EnLink Midstream (NYSE:ENLC) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday.

  • [By Max Byerly]

    Dimensional Fund Advisors LP increased its position in shares of EnLink Midstream LLC (NYSE:ENLC) by 13.6% during the first quarter, HoldingsChannel reports. The institutional investor owned 3,173,164 shares of the pipeline company’s stock after buying an additional 378,910 shares during the quarter. Dimensional Fund Advisors LP’s holdings in EnLink Midstream were worth $46,487,000 as of its most recent filing with the SEC.

Hot Low Price Stocks To Watch Right Now: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news stories that may have impacted Accern’s rankings:

    Get TrovaGene alerts:

    Average True Range under Consideration: TrovaGene, Inc. (NASDAQ:TROV), USD Partners LP (NYSE:USDP), Tiptree … ( Take These As A Wake-Up Call: TrovaGene, Inc. (NASDAQ:TROV), PPDAI Group Inc. (NYSE:PPDF), Inseego Corp … ( Review of Financial analysis: TrovaGene, Inc., (NASDAQ: TROV), Redwood Trust, Inc., (NYSE: RWT) ( In which scenario TrovaGene, Inc. (TROV) and Urban Outfitters, Inc. (URBN) are Trading Now? ( Analysts’ Views: Sumitomo Mitsui Financial Group Inc (SMFG) and Trovagene Inc (TROV) (

    TROV has been the topic of several recent research reports. Maxim Group reiterated a “hold” rating on shares of TrovaGene in a report on Monday, March 5th. HC Wainwright reiterated a “buy” rating and set a $12.00 target price on shares of TrovaGene in a report on Tuesday, March 6th. ValuEngine cut shares of TrovaGene from a “sell” rating to a “strong sell” rating in a report on Monday, April 2nd. Finally, Zacks Investment Research cut shares of TrovaGene from a “buy” rating to a “hold” rating in a report on Thursday, May 3rd. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. TrovaGene currently has an average rating of “Buy” and a consensus target price of $19.17.

  • [By Logan Wallace]

    TrovaGene Inc (NASDAQ:TROV) has been assigned a consensus rating of “Hold” from the six research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.00.

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) fell more than 55% Friday to post a new 52-week low of $0.79 after closing at $1.77 on Thursday. The 52-week high is $19.56. Volume of around 11 million was nearly five times the daily average of about 230,000. The company announced a public offering of $18 million in stock and warrants priced at $1.00 for the unit.

Hot Low Price Stocks To Watch Right Now: Duke Energy Corporation(DUK)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer, Rich Smith, and Sean Williams]

    If you’ve entered your retirement years, then your investment goals have likely shifted from wealth accumulation to living off the wealth you have created. That, in turn, likely means you’re looking for a mix of dividend income and safety. Here are these Motley Fool investors’ choices of three high-yield stocks that offer just that, by providing customers with services they simply can’t live without: AT&T Inc. (NYSE:T), NextEra Energy Inc. (NYSE:NEE), and Duke Energy Corporation (NYSE:DUK).

  • [By Chris Lange]

    Duke Energy Corp.’s (NYSE: DUK) fourth-quarter results are scheduled for Tuesday. The consensus estimates are calling for $0.92 in earnings per share (EPS) on $6.17 billion in revenue. The shares traded on Friday’s close at $76.70. The consensus price target is $85.67, and the 52-week trading range is $72.93 to $91.80.

  • [By ]

    Another interesting trend is big energy companies like Duke Energy (NYSE: DUK) offering their own rebate programs to spark sales of rooftop solar installations — a trend that would certainly help SEDG.

  • [By Reuben Gregg Brewer]

    Investing in retirement requires a different focus, usually one that includes a prominent place for dividend income. If dividend-paying stocks are what you’re looking for, then you should take a closer look at high-yielding Duke Energy Corporation (NYSE:DUK), ONEOK, Inc. (NYSE:OKE), and W.P. Carey Inc. (NYSE:WPC). They offer dividend yields of 4%, 5%, and 6%, respectively… income that could materially increase your retirement “paycheck” and help to supplement Social Security.

Hot Low Price Stocks To Watch Right Now: Corindus Vascular Robotics, Inc.(CVRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Corindus Vascular Robotics (NYSEAMERICAN:CVRS) released its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.08) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.03), Bloomberg Earnings reports. The business had revenue of $1.49 million for the quarter, compared to the consensus estimate of $3.20 million. Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Corindus Vascular Robotics (CVRS)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Alexander Bird]

    Here are the top performers from last week…

    Penny Stock Current Share Price Last Week’s Gain
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
    Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
    Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
    Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
    Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
    Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
    Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
    Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
    ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
    SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%

    While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.

Hot Low Price Stocks To Watch Right Now: Two River Bancorp(TRCB)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Two Rivers Bancorp (NASDAQ:TRCB) have trended somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Two Rivers Bancorp earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.3815117771449 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Leave a Reply

Your email address will not be published.